David Steinberg analyst

Currently out of the existing stock ratings of David Steinberg, 162 are a BUY (86.17%), 25 are a HOLD (13.3%), 1 are a SELL (0.53%).

David Steinberg

Work Performance Price Targets & Ratings Chart

Analyst David Steinberg, has had 69.27% of price targets met with an average potential upside of 30.99%, reached in 298 days on average. Previously, David Steinberg worked at JEFFERIES.

David Steinberg has documented 365 price targets and ratings displayed on 27 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ZTS, Zoetis at 17-Feb-2022.

Wall Street Analyst David Steinberg

Analyst best performing recommendations are on SGNT (SAGENT PHARMACEUTICALS).
The best stock recommendation documented was for SUPN (SUPERNUS PHARMACEUTICALS) on 6/15/2020. The price target of $24 was fulfilled within 1 day with a profit of $0.93 (4.03%), with a performance score of 40.31.

Average potential price target upside

ACRS Aclaris Therapeutics AKRX Akorn AMPH Amphastar P BHC Bausch Health Companies CORI Corium International HZNP Horizon Pharma PLC JAZZ Jazz Pharmaceuticals PLC NKTR Nektar Therapeutics PRGO Perrigo Company PLC SUPN Supernus Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR ZTS Zoetis INSY INSYS Therapeutics PCRX Pacira Pharmaceuticals AGN Allergan plc COLL Collegium Pharmaceutical OPTN OptiNose OSMT Osmotica Pharmaceuticals plc MNLO Menlo Therapeutics PHAT Phathom Pharmaceuticals RVLP RVL Pharmaceuticals PLC OCUL Ocular Therapeutix SGNT Sagent Pharmaceuticals VRCA Verrica Pharmaceuticals XERS Xeris Pharmaceuticals SLGL Sol Gel Technologies Ltd SCPH Scpharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-May-2025

$3

$-0.61 (-16.90%)

$8

2 days ago
(16-Nov-2026)

Buy Since 13-May-2025

$16

$12.39 (343.21%)

$16

22 days ago
(27-Oct-2026)

0/11 (0%)

$12.21 (322.16%)

Hold Since 05-Nov-2024

$4

$0.39 (10.80%)

$3

6 months 11 days ago
(07-May-2026)

4/5 (80%)

$-0.93 (-18.86%)

50

Buy Since 04-May-2026

$11

$7.39 (204.71%)

$6

6 months 14 days ago
(04-May-2026)

1/2 (50%)

$6.25 (131.58%)

391

Buy Since 28-Nov-2016

$12

$8.39 (232.41%)

6 months 14 days ago
(04-May-2026)

0/2 (0%)

$7.25 (152.63%)

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?